2017
DOI: 10.1016/j.radonc.2016.10.016
|View full text |Cite
|
Sign up to set email alerts
|

Three-dimensional analysis of patterns of locoregional recurrence after treatment in breast cancer patients: Validation of the ESTRO consensus guideline on target volume

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
55
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 55 publications
(59 citation statements)
references
References 25 publications
4
55
0
Order By: Relevance
“…Previously, the same group published their single institution results, from patients treated in an earlier era . The findings were similar to the multi‐institutional study (and there may have been overlap in cases).…”
Section: Resultssupporting
confidence: 76%
See 4 more Smart Citations
“…Previously, the same group published their single institution results, from patients treated in an earlier era . The findings were similar to the multi‐institutional study (and there may have been overlap in cases).…”
Section: Resultssupporting
confidence: 76%
“…The exact frequency and risk of this recurrence is difficult to assess, and reflects the composition of the case series, with higher rates of theoretical ‘miss’ associated with higher nodal disease burden, stage IV disease, and possibly lower rates of current standard chemotherapy. In both papers by Chang et al ., which only examined recurrent lesions, the rate of SCF LN metastases outside the ESTRO/RTOG CTV was lower than in the other two series, which also included patients who presented with SCF metastases at diagnosis . However, taken together, these studies suggest that the posterior volume, which extends beyond the scalene muscles, is at risk from metastatic breast cancer.…”
Section: Discussionmentioning
confidence: 89%
See 3 more Smart Citations